Data as of Apr 17
| +0.0028 / +0.82%|
The 2 analysts offering 12-month price forecasts for Elite Pharmaceuticals Inc have a median target of 4.25, with a high estimate of 4.50 and a low estimate of 4.00. The median estimate represents a +1,132.60% increase from the last price of 0.34.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.